Erschienen in:
01.04.2008 | Poster presentation
A multicenter randomized controlled clinical trial comparing central venous catheters impregnated with either 5-fluorouracil or chlorhexidine/silver sulfadiazine in preventing catheter colonization
verfasst von:
JM Walz, J Luber, J Reyno, G Stanford, R Gitter, KJ Longtine, JK Longtine, MA O'Neill, SO Heard
Erschienen in:
Critical Care
|
Sonderheft 2/2008
Einloggen, um Zugang zu erhalten
Excerpt
We conducted a national multicenter randomized clinical trial to compare the efficacy of a novel anti-infective central venous catheter (CVC) coated with 5-fluorouracil (5-FU) (Angiotech Pharmaceuticals, Vancouver, Canada) with a catheter coated with chlorhexidine and silver sulfadiazine (CH-SS) (ARROWgard Blue; Arrow International, Inc., Reading, PA, USA) in preventing catheter colonization, local site infection and catheter-related bloodstream infection (CRBSI). …